Riskpilot← Back to searchSign inGet full accessOneMed Group Oy
OYActiveY-tunnus 2039640-1Metsäläntie 20Wholesale of pharmaceutical and medical goods · NACE 4646Est. 2006— employeeswww.onemed.com
Revenue 2025
EUR 721K
+8% vs 2024
EBITDA margin
-67.6%
-1210% vs 2024
Equity ratio
—
Financial strength
Net profit 2025
EUR 8
-100% vs 2024
| Revenue | EUR 721K | +8% |
| EBITDA | EUR -488K | -1210% |
| Net profit | EUR 8 | -100% |
| Total assets | EUR 0 | -100% |
| Equity | EUR 0 | -100% |
| Employees | — | — |
Legal name
OneMed Group Oy
Y-tunnus number
2039640-1
Legal form
Osakeyhtiö
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
23. toukokuuta 2006
Share capital
EUR 3 179 502
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Hallituksen jäsen ja toimitusjohtaja yhdessä sekä hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimialana on itse tai omistamiensa yhtiöiden kautta harjoittaa terveydenhoito- ja laboratorioalan tuotteiden, kemikaalien ja sairaalatarvikkeiden kauppaa, laitteiden huoltoa sekä näihin liittyviä toimintoja sekä näitä toimintoja harjoittavien yhtiöiden omistaminen sekä hallinto-, rahoitus- (sisältäen myös vakuuksien ja takauksien antamisen omistamiensa yhtiöiden puolesta) ja kirjanpitopalvelujen tuottaminen näille yhtiöille. Lisäksi yhtiö voi harjoittaa muuta tähän läheisesti liittyvää toimintaa. Yhtiö voi omistaa, vuokrata ja hallita kiinteistöjä sekä omistaa osakkeita ja muita arvopapereita ja harjoittaa arvopaperikauppaa.
Address
Metsäläntie 20
Phone
+3580467146800
Website
www.onemed.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 418 | 722 | 636 | 667 | 721 |
| Staff expenses | −300 | −334 | −382 | −360 | −326 |
| EBITDA | −114 | 74 | 45 | 44 | −488 |
| Depreciation & amort. | −1 740 | −1 720 | −487 | −373 | −249 |
| EBIT | −1 854 | −1 647 | 0 | −329 | −736 |
| Net financials | 89 | −19 972 | 0 | 74 625 | −154 |
| Profit before tax | −8 | −21 186 | 0 | 75 001 | 0 |
| Tax | −2 | −1 | −0 | −1 | 0 |
| Net profit | −6 | −21 185 | 0 | 75 002 | 0 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 134 303 | 135 921 | 0 | 127 595 | 0 |
| Equity | 105 872 | 118 587 | 118 580 | 120 835 | 0 |
| Long-term debt | 9 240 | — | 0 | 0 | 0 |
| Short-term debt | 19 191 | 17 334 | 9 080 | 6 760 | 0 |
| Total debt | 28 431 | 17 334 | 9 080 | 6 760 | 0 |
EBITDA margin
-67.6%
This company
15.8%
Market median
-528% vs market
20212025
Equity ratio
0.0%
This company
38.2%
Market median
-100% vs market
20212025
Return on equity
800.0%
This company
18.4%
Market median
+4248% vs market
20212025
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20212025
Asset turnover
721288.00×
This company
1.12×
Market median
+64400614% vs market
20212025
Debt / equity
-1.00×
This company
0.62×
Market median
+261% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HM Chief Executive Officer | Chief Executive Officer | 2024 |
| Former (5) | ||
TT Person with significant control | Person with significant control | 2018 – 2019 |
AJ Audit | Audit | 2019 – 2023 |
CJ Chief Executive Officer | Chief Executive Officer | 2012 – 2022 |
MO Chief Executive Officer | Chief Executive Officer | 2022 – 2024 |
KP Audit | Audit | 2018 – 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairperson | 2024 | |
| Board of Directors | 2022 | |
| Former (3) | ||
| Board of Directors | 2018 – 2019 | |
| Board of Directors | 2019 – 2022 | |
| Board of Directors | 2018 – 2019 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
OneMed Group Oy 
OneMed OyBoard members of OneMed Group Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tiia Terhikki Räisänen | Person with significant control | 0 companies |
| Anders Johan Svennas | Audit | 0 companies |
| Carl Johan Falk | Chief Executive Officer | 0 companies |
| Markus Oskari Henriksson | Chief Executive Officer | 0 companies |
| Kari Pekka Ruskola | Audit | 0 companies |
| Hanna-Leena Merikanto | Chief Executive Officer | 0 companies |
| Lars Olof Ragnar Ingman | Board of Directors | 0 companies |
| Lars Peter Nilsson | Chairperson | 0 companies |
| Thomas Philip Moss | Board of Directors | 0 companies |
| Juha Pekka Kallioniemi | Board of Directors | 0 companies |
| Julien Alain Rolland | Board of Directors | 0 companies |